Clinical Study to Evaluate Impact of PerioPredict Genetic Risk Testing
WALTHAM, Mass., March 29, 2016 (GLOBE NEWSWIRE) — Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for


